Abstract:Transforming growth factor β (TGFβ) is a multifunctional cytokine that is involved in many biological effects, such as proliferation, migration, differentiation and cell survival. TGFβ regulates cellular responses by binding to a heteromeric complex of type I and type II serine/threonine kinase receptors. The type I receptor, termed activin receptor-like kinase (ALK), acts downstream of the type II receptor and propagates the signal to the nucleus by phosphorylating receptor regulated Smads (R-Smads). The activated R-Smads can associate with the common partner Smad, Smad4, and this complex translocates to the nucleus where it participates in transcriptional regulation of target genes. TGFβ plays an important role in vascular morphogenesis. The aim of this study was to obtain more insight into the mechanisms by which TGFβ can act as an inhibitor or stimulator of angiogenesis Our findings show that in endothelial cells (ECs), TGFβ can activate two distinct type I receptor/Smad signalling pathways with opposite cellular responses. In most cell types, TGFβ signals via the TGFβ type I receptor, ALK5. However, ECs express a predominant endothelial type I receptor, named ALK1. Whereas the TGFβ/ALK1 signalling leads to activation, the TGFβ/ALK5 pathway results in an inhibition of the activation state. This suggests that TGFβ regulates the activation state of the endothelium via a fine balance between these two pathways. We identified genes that are specifically induced by TGFβ mediated ALK1 or ALK5 activation. Id1 was found to be the target gene of the ALK1/Smad1/5 pathway while induction of plasminogen activator inhibitor-1 was activated only by ALK5/Smad2 pathway. Furthermore, ALK1 activated ECs are highly invasive but this property is lost if Id1 expression is specifically knocked-down. ECs invasiveness is highly dependent on αv integrin binding to its extracellular matrix (ECM) protein partner and the invasion requires proteolytic cleavage of the ECM by metalloproteases (MMPs). Hence, TGFβ/ALK1/Id1 pathway may promote invasion by modulating the expression or activity of integrins and MMPs that are well known components of the ECM. Timing and duration of TGFβ signalling are important specificity determinants for its effect on cellular behaviour. After binding to ALK1, TGFβ induces a transient phosphorylation of Smad1/5 but a stable phosphorylation of Smad2 via ALK5. Our studies indicate that Smad7 is potently induced by ALK1 signalling and may recruit a PP1α/TIMAP phosphatase complex to ALK1 to dephosphorylate the receptor and thereby turning off phosphorylation resulting in a temporal activation of TGFβ/ALK1-induced Smad1/5 pathway. This mechanism enables an efficient and tightly temporally controlled activation resulting in the dominance of ALK5 upon prolonged exposure to TGFβ. Bone morphogenetic protein (BMP) is a member of the TGFβ superfamily and signals through Smad1/5. The BMP/Smad1/5 pathway was found to potently activate the endothelium. Id1 was identified as an important BMP target gene in ECs and was sufficient and necessary for BMP-induced EC migration. These studies not only provide new insights into possible molecular mechanisms that underlie activation and quiescence of ECs during physiological angiogenesis but may also explain the vascular phenotypes observed in mice and humans with perturbed TGFβ signalling pathways.

Stimulation of Id1 Expression by Bone Morphogenetic Protein is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter*

Controlling Cell Fate By Bone Morphogenetic Protein Receptors

Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells

Opposing Actions of TGFβ Signalling Via ALK1 or ALK5 on Cord-like Network Formation and Invasion of Endothelial Cells

The Activation of Notch Antagonizes BMP Receptor-induced Endothelial Cell Migration Via Synergistic Induction of Herp2 Expression

S150 Smad-dependent and Smad-independent Induction of Id1 by Prostacyclin Analogues Inhibits Proliferation of Pulmonary Artery Smooth Muscle Cells in Vitro and in Vivo

Id1 Induces Tubulogenesis By Regulating Endothelial Cell Adhesion And Cytoskeletal Organization Through Beta 1-Integrin And Rho-Kinase Signalling

Β3 Integrin–mediated Spreading Induced by Matrix-Bound BMP-2 Controls Smad Signaling in a Stiffness-Independent Manner

Expression And Function Of The Id1 Gene During Transforming Growth Factor-Beta 1-Induced Differentiation Of Human Embryonic Stem Cells To Endothelial Cells

BONE MORPHOGENETIC PROTEIN 2 PROMOTES HUMAN TROPHOBLAST CELL INVASION AND ENDOTHELIAL-LIKE TUBE FORMATION THROUGH ID1-MEDIATED UP-REGULATION OF IGF BINDING PROTEIN-3

Bmp2 and Vegf Promote Angiogenesis but Retard Terminal Differentiation of Osteoblasts in Bone Regeneration by Up-Regulating Id1

Expression and Function of the<i>ID1</i>Gene During Transforming Growth Factor-β1-Induced Differentiation of Human Embryonic Stem Cells to Endothelial Cells

Bone Morphogenetic Protein Signalling in Ngf-Stimulated Pc12 Cells

[The Role of Smads and Related Transcription Factors in the Signal Transduction of Bone Morphogenetic Protein Inducing Bone Formation].

Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts

BMP receptor-integrin interaction mediates responses of vascular endothelial Smad1/5 and proliferation to disturbed flow.

BMP-9 Signals Via ALK1 and Inhibits Bfgf-Induced Endothelial Cell Proliferation and VEGF-stimulated Angiogenesis

Mechanical Activation of Smad, A Novel Regulator for Endothelial Cell Proliferation Induced by Disturbed Flow

Id Proteins Are Critical Downstream Effectors of BMP Signaling in Human Pulmonary Arterial Smooth Muscle Cells.

Synergy and Antagonism Between Notch and BMP Receptor Signaling Pathways in Endothelial Cells.